Table 6 Association of different risk factors with enterococci colonization
Factors | No. of patients (n = 110) | VSE nasal enterococci (n = 26) | VSE perirectal enterococci (n = 50) | VRE nasal (n = 3) | VRE perirectal (n = 6) | ||
|---|---|---|---|---|---|---|---|
| Â | Number (%) | E. faecalis(%) | E. faecium(%) | E. faecalis(%) | E. faecium(%) | E. faecalis | E. faecalis |
| Â | Â | Â | Â | Â | Â | E. faecium(%) | E. faecium(%) |
Age of patients | |||||||
· <1 | 69 (62.7) | 8 (30.8) | 12 (46.2) | 17 (34) | 14 (28) | 1 (33.3) | 2 (33.3) |
· 1 to <6 | 29 (26.4) | 0 | 5 (19.2) | 7 (14) | 7 (14) | 1 (33.3) | 3 (50) |
· 6 to <12 | 12 (10.9) | 1 (3.9) | 0 | 2 (4) | 3 (6) | 1 (33.3) | 1 (16.7) |
Reason for Admission | |||||||
· Miscellaneous group | 26 (23.6) | 2 (7.7) | 3 (11.5) | 7(14) | 9 (18) | 1 (33.3) | 1 (16.7) |
· Aspiration Pneumonia | 1 (0.9) | 0 | 0 | 1 (2) | 0 | 0 | 0 |
· Meningitis | 11 (10) | 0 | 1 (3.9) | 3 (6) | 1 (2) | 0 | 2 (33.3) |
· Pneumonia | 68 (61.8) | 7 (26.9) | 13 (50) | 15 (30) | 14 (28) | 2 (66.7) | 3 (50) |
· Renal Failure | 2 (1.8) | 0 | 0 | 0 | 0 | 0 | 0 |
· Tuberculosis | 2 (1.8) | 0 | 0 | 0 | 0 | 0 | 0 |
Duration of stay | |||||||
· 0 day | 13 (11.8) | 3 (11.5) | 3 (11.5) | 6 (12) | 2 (4) | 0 | 0 |
· 1 day | 13 (11.8) | 0 | 1 (3.9) | 3 (6) | 3 (6) | 0 | 1 (16.7) |
· 2 days | 20 (18.2) | 3 (11.5) | 3 (11.5) | 5 (10) | 5 (10) | 1 (33.3) | 1 (16.7) |
· 3 to 5 days | 24 (21.8) | 1 (3.9) | 3 (11.5) | 5 (10) | 4 (8) | 0 | 0 |
· 6 to 10 days | 22 (20) | 2 (7.7) | 5 (19.2) | 4 (8) | 8 (16) | 0 | 1 (16.7) |
· >10 days | 18 (16.4) | 0 | 2 (7.7) | 3 (6) | 2 (4) | 2 (66.7) | 3 (50) |
Residential Status | |||||||
· Rural | 48(43.6) | 2 (7.7) | 6 (23.1) | 9 (18) | 11 (22) | 0 | 1 (16.7) |
· Urban | 62 (56.4) | 7 (26.9) | 11 (42.3) | 17 (34) | 13 (26) | 3 (100) | 5 (83.3) |
Socioeconomic Status | |||||||
· Lower Class | 69 (62.7) | 4 (15.4) | 9 (34.6) | 9 (18) | 13 (26) | 3 (100) | 6 (100) |
· Middle Class | 40 (36.4) | 5 (19.2) | 8 (30.8) | 16 (32) | 11 (22) | 0 | 0 |
· Higher Class | 1 (0.9) | 0 | 0 | 1 (2) | 0 | 0 | 0 |
Vancomycin use | |||||||
· Yes | 14 (12.7) | 2 (7.7) | 3 (11.5) | 4 (8) | 1 (2) | 1(33.3) | 3 (50) |
· No | 96 (87.3) | 7 (26.9) | 14 (53.8) | 22 (44) | 23 (46) | 2 (66.7) | 3 (50) |